CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy CHIEF LEGAL OFFICER bought 300,000 shares at $0.17 ($50,910)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 600,000 shares at $0.17 ($103,200)
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Grant or award VP, CFO AND SECRETARY acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 5,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 5,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 60,000 shares at $0.89 ($53,400)
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Executive or director change · Other events
- 8-K Event Regulation FD disclosure
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 100,000 shares (option exercise)
- 8-K Event Other events
Page 14 of 46 · 909 filings